Storage lesion in banked blood due to hemolysis-dependent disruption of nitric oxide homeostasis

Current Opinion in Hematology

Volumn 16, Issue 6, 2009, Pages 515-523

  Gladwin, Mark T ^a   Kim Shapiro, Daniel B ^b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

Author keywords

Arginase; Hemoglobin; Hemolysis; Nitric oxide; Nitrite; Red blood cells

Indexed keywords

ARGINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEMOGLOBIN; NITRIC OXIDE; NITRITE;

BLOOD STORAGE; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ERYTHROCYTE METABOLISM; HEMOSTASIS; HUMAN; INTRAVASCULAR HEMOLYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REACTION ANALYSIS; REVIEW; THROMBOCYTE ACTIVATION; BLOOD; BLOOD BANK; CHEMISTRY; ERYTHROCYTE; HEMOLYSIS; HOMEOSTASIS; METABOLISM;

BLOOD BANKS; BLOOD PRESERVATION; ERYTHROCYTES; HEMOLYSIS; HOMEOSTASIS; HUMANS; NITRIC OXIDE;

EID: 73949089031     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32833157f4     Document Type: Review

References (117)

1. Greenwalt TJ, Bryan DJ, Dumaswala UJ. Erythrocyte-membrane vesiculation and changes in membrane-composition during storage in citrate-phosphatedextrose- adenlne-1. Vox Sanguinis 1984; 47:261-270.
2. Rumsby MG, Trotter J, Allan D, Michell RH. Recovery of membrane microvesicles from human erythrocytes stored for transfusion: mechanism for erythrocyte discocyte-to-spherocyte shape transformation. Biochem Soc Trans 1977;5:126-128.
3. Dern RJ, Brewer GJ, Wiorkowski JJ. Studies on the preservation of human blood. II. The relationship of erythrocyte adenosine triphosphate levels and other in vitro measures to red cell storage ability. J Lab Clin Med 1967; 69:968-978.
4. Berezina TL, Zaets SB, Morgan C, et al. Influence of storage on red blood cell rheologlcal properties. J Surg Res 2002; 102:6-12.
5. Haradin AR, Weed RI, Reed CF. Changes in physical properties of stored erythrocytes. Transfusion 1969; 9:229-235.
6. Silliman CC, Clay KL, Thurman GW, et al. Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase. J Lab Clin Med 1994; 124:684-694.
7. Beutler E, Kuhl W. Volume control of erythrocytes during storage: the role of mannitol. Transfusion 1988; 28:353-357.
8. Latham JT, Bove JR, Weirich FL. Chemical and hematologic changes in stored CPDA-1 blood. Transfusion 1982; 22:158-159.
9. Greenwalt TJ, Sostok CZ, Dumaswala UJ. Studies in red-blood-cell preservation 0.2. Comparison of vesicle formation, morphology, and membranelipids during storage in as-1 and Cpda-1. Vox Sanguinis 1990; 58:90-93.
10. Chanutin A, Curnish RR. Effect of organic phosphates on the 02 equilibrium of carboxypeptidase digests of human hemoglobin. Arch Biochem Biophys 1968; 123:163-165.
11. Beutler E, Meul A, Wood LA. Depletion and regeneration of 2,3diphosphoglyceric acid in stored red blood cells. Transfusion 1969; 9:109-115.
12. Bunn HF, May MH, Kocholaty WF, Shields CE. Hemoglobin function in stored blood. J Clin Invest 1969; 48:311-321.
13. Klein HG, Spahn DR, Carson JL. Transfusion medicine 1: red blood cell transfusion in clinical practice. Lancet 2007; 370:415-426.
14. Tinmouth A, Fergusson D, Yee IC, Hebert PC. Clinical consequences of red cell storage in the critically ill. Transfusion 2006; 46:2014-2027. (Pubitemid 44631611)
15. Zallen G, Offner PJ, Moore EE et al. Age of transfused blood is an independent risk factor for postinjury multiple organ failure. Am J Surg 1999; 178:570-572.
16. Moore FA, Moore EE, Sauaia A. Blood transfusion: an independent risk factor for postinjury multiple organ failure. Arch Surg-Chicago 1997; 132:620625.
17. Marik PE, Sibbald WJ. Effect of stored-blood transfusion on oxygen delivery in patients with sepsis. J Am Med Assoc 1993; 269:3024-3029. (Pubitemid 23164346)
18. Offner PJ, Moore EE, Biffl WL, et al. Increased rate of Infection associated with transfusion of old blood after severe injury. Arch Surg-Chicago 2002; 137:711-716.
19. Purdy FR, Tweeddale MG, Merrick PM. Association of mortality with age of blood transfused In septic ICU patients. Can J Anaesth 1997; 44:12561261.
20. Leal-Noval SR, Jara-Lopez I, Garcia-Garmendia JL, et al. Influence of erythrocyte concentrate storage time on postsurgical morbidity in cardiac surgery patients. Anesthesiology 2003; 98:815-822.
21. Walsh TS, McArdle F, McLellan SA, et al. Does the storage time of transfused red blood cells influence regional or global indexes of tissue oxygenation in anemic critically ill patients? Crit Care Med 2004; 32:364-371.
22. Klein HG. Getting older is not necessarily getting better. Anesthesiology 2003; 98:807-808. (Pubitemid 36373211)
23. Adamson JW. New blood, old blood, or no blood? N Engl J Med 2008; 358:1295-1296.
24. Vamvakas EC, Carven JH. Length of storage of transfused red cells and postopeative morbidity in patients undergoing coronary artery bypass graft surgery. Transfusion 2000; 40:101-109.
25. de Watering LV, Lorinser J, Versteegh M, et al. Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients. Transfusion 2006; 46:1712-1718.
26. Koch CG, Li L, Sessler Dl, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008; 358:1229-1239.
27. d'Almeida MS, Jagger J, Duggan M, et al. A comparison of biochemical and functional alterations of rat and human erythrocytes stored in CPDA-1 for 29 days: Implications for animal models of transfusion. Transfusion Med 2000; 10:291-303.
28. Izzo P, Manicone A, Spagnuolo A, et al. Erythrocytes stored in CPD SAGmannitol: evaluation of their deformability. Clin Hemorheol Micro 1999; 21:335-339. (Pubitemid 30130915)
29. Card RT, Mohandas N, Mollison PL. Relationship of post-transfusion viability to deformability of stored red-cells. Br J Haematol 1983; 53:237-240. (Pubitemid 13171496)
30. Card RT, Mohandas N, Perkins HA, Shohet SB. Deformability of stored redblood-cells: relationship to degree of packing. Transfusion 1982; 22:96101.
31. Aubuchon JP, Estep TN, Davey RJ. The Effect of the plasticizer di-2-ethylhexyl phthalate on the survival of stored RBCs. Blood 1988; 71:448-452.
32. Salzer U, Zhu R, Luten M, et al. Vesicles generated during storage of red cells are rich in the lipid raft marker stomatin. Transfusion 2008; 48:451-462. (Pubitemid 351294572)
33. Greenwalt TJ, McGuinness CG, Dumaswala UJ. Studies in red-blood-cell preservation 0.4. Plasma vesicle hemoglobin exceeds free hemoglobin. Vox Sanguinis 1991; 61:14-17.
34. Dumaswala UJ, Dumaswala RU, Levin DS, Greenwalt TJ. Improved red blood cell preservation correlates with decreased loss of bands 3, 4.1, acetylcholinestrase, and lipids in microvesicles. Blood 1996; 87:1612-1616.
35. Lutz HU, Liu SC, Palek J. Release of speotrin-free vesicles from human erythrocytes during ATP depletion. 1. Characterization of spectrin-free vesicles. J Cell Biol 1977; 73:548-560.
36. Kim-Shapiro DB. Unraveling the reactions of nitric oxide, nitrite, and hemoglobin in physiology and therapeutics. Arterloscler Thromb Vase Biol 2006; 26:697.
37. Schmidt PM, Schramm M, Schroder H, et al. Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase. J Biol Chem 2004; 279:3025-3032.
38. Patel RP, McAndrew J, Sellak H, et al. Biological aspects of reactive nitrogen species [Review]. Biochim Biophys Acta-Bioenerg 1999; 1411:385-400. (Pubitemid 29221963)
39. Hsu LL, Champion HC, Campbell-Lee SA, et al. Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood 2007; 109:3088-3098.
40. Kaul DK, Zhang XQ, Dasgupta T, Fabry ME. Arginine therapy of transgenicknockout sickle mice improves microvascular function by reducing nonnitric oxide vasodilators, hemolysis, and oxidative stress. Am J Physiol-Heart Circul Physiol 2008; 295:H39-H47.
41. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth-muscle by acetylcholine. Nature 1980; 288:373-376.
42. lgnarro Lj, Byrns RE, Buga GM, Wood KS. Endothelium-derived relaxing factor from pulmonary-artery and vein possesses pharmacological and chemical properties identical to those of nitric-oxide radical. Circ Res 1987; 61:866-879.
43. Katsuki S, Arnold W, Mittal C, Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric-oxide in various tissue preparations and comparison to effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res 1977; 3:23-35. (Pubitemid 8078230)
44. Paimer RMJ, Ferrige AG, Moncada S. Nitric-oxide release accounts for the biological-activity of endothelium-derived relaxing factor. Nature 1987; 327:524-526. (Pubitemid 17085822)
45. Lancaster JR. Simulation of the diffusion and reaction of endogenously produced nitric-oxide. Proc Natl Acad Sci USA 1994; 91:8137-8141.
46. Doyle MP, Hoekstra JW. Oxidation of nitrogen-oxides by bound dioxygen in hemoproteins. J Inorg Biochem 1981; 14:351-358.
47. Eich RF, Li TS, Lemon DD, et al. Mechanism of NO-induced oxidation of myoglobin and hemoglobin. Biochemistry-US 1996; 35:6976-6983.
48. Herold S, Exner M, Nauser T. Kinetic and mechanistic studies of the NO center dot-mediated oxidation of oxymyoglobin and oxyhemoglobin. Biochemistry-US 2001 ; 40:3385-3395. (Pubitemid 32221642)
49. Cassoly R, Gibson QH. Conformation, co-operativity and ligand-binding in human hemoglobin. J Mol Biol 1975; 91:301-313.
50. Sharma VS, Ranney HM. Dissociation of NO from nitrosylhemoglobin. J Biol Chem 1978; 253:6467-6472.
51. Azizi F, Shields H, Yakubu M, et al. Measurements of the rate of hemoglobin denitrosylation. Biophys J 2003; 84:33a-133a.
52. Cooper CE. Nitric oxide and iron proteins. Biochim Biophys Acta-Bioenerg 1999; 1411:290-309.
53. Moore EG, Gibson QH. Cooperativity in dissociation of nitric-oxide from hemoglobin. J Biol Chem 1976; 251:2788-2794.
54. Carlsen E, Comroe JH. The rate of uptake of carbon monoxide and of nitric oxide by normal and human erythrocytes and experimentally produced spherocytes. J Gen Physiol 1958; 42:83-107.
55. Coin JT, Olson JS. Rate of oxygen-uptake by human red blood-cells. J Biol Chem 1979; 254:1178-1190.
56. Butler AR, Megson IL, Wright PG. Diffusion of nitric oxide and scavenging by blood in the vasculature. Biochim Biophys Acta 1998; 1425:168-176. (Pubitemid 28479723)
57. Vaughn MW, Kuo L, Liao JC. Estimation of nitric oxide production and reaction rates In tissue by use of a mathematical model. Am J Physiol-Heart Circul Physiol 1998; 43:H2163-H2176. (Pubitemid 28308838)
58. Liao JC, Hein TW, Vaughn MW, et al. Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc Natl Acad Sci USA 1999; 96:87578761.
59. Vaughn MW, Huang KT, Kuo L, Liao JC. Erythrocytes possess an intrinsic barrier to nitric oxide consumption. J Biol Chem 2000; 275:2342-2348. (Pubitemid 30081991)
60. Vaughn MW, Huang KT, Kuo L, Liao JC. Erythrocyte consumption of nitric oxide: competition experiment and model analysis. Nitric Oxide-Biol Ch 2001;5:18-31. (Pubitemid 34146168)
61. Liu XP, Samouilov A, Lancaster JR, Zweier JL. Nitric oxide uptake by erythrocytes is primarily limited by extracellular diffusion not membrane resistance. J Biol Chem 2002; 277:26194-26199. (Pubitemid 34967106)
62. Huang KT, Han TH, Hyduke DR, et al. Modulation of nitric oxide bioavailability by erythrocytes. Proc Natl Acad Sci USA 2001 ; 98:11771-11776. (Pubitemid 32928804)
63. Liu XP, Miller MJS, Josh MS, et al. Diffusion-limited reaction of free nitric oxide with erythrocytes. J Biol Chem 1998; 273:18709-18713.
64. Azarov I, Huang KT, Basu S, et al. Nitric oxide scavenging by red blood cells as a function of hematocrit and oxygenation. J Biol Chem 2005; 280:39024-39032. (Pubitemid 41713852)
65. Vaughn MW, Kuo L, Liao JC. Effective diffusion distance of nitric oxide in the microcirculation. Am J Physiol-Heart Circul physiol 1998; 43:H1705H1714. (Pubitemid 128784822)
66. Han TH, Liao JC. Erythrocyte nitric oxide transport reduced by a submembrane cytoskeletal barrier. Biochim Biophys Acta 2005; 1723:135-142.
67. Vogel WM, Dennis RC, Cassidy G, et al. Coronary constrictor effect of stroma-free hemoglobin-solutions. Am J Physiol 1986; 251:H413-H420.
68. Hess JR, Macdonald VW, Brinkley WW. Systemic and pulmonary-hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol 1993; 74:1769-1778.
69. Lee R, Neya K, Svizzero TA, Vlahakes GJ. Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions. J Appl Physiol 1995; 79:236242.
70. Murray JA, Ledlow A, Launspach J, et al. The effects of recombinant human hemoglobin on esophageal motor function in humans. Gastroenterology 1995; 109:1241-1248.
71. Ulatowski JA, Nishikawa T, MathesonUrbaitis B. et al. Regional blood flow alterations after bovine fumaryl beta beta-crosslinked hemoglobin transfusion and nitric oxide synthase inhibition. Crit Care Med 1996; 24:558-565.
72. Sloan EP, Koenigsberg M, Gens D, et al. Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. J Am Med Assoc 1999; 282:1857-1864.
73. Dou Y, Maillett DH, Eich RF, Olson JS. Myoglobin as a model system for designing heme protein based blood substitutes. Biophys Chem 2002; 98:127-148. (Pubitemid 34785987)
74. Doherty DH, Doyle MP, Curry SR, et al. Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nature Biotechnol 1998; 16:672-676.
75. Olson JS, Foley EW, Rogge C, et al. No scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic Biol Med 2004; 36:685-697.
76. Patel RP. Biochemical aspects of the reaction of hemoglobin and NO: implications for Hb-based blood substitutes. Free Radio Biol Med 2000; 28:1518-1525.
77. Gulati A, Barve A, Sen AP. Pharmacology of hemoglobin therapeutics. J Lab Clin Med 1999; 133:112-119.
78. Abassi Z, Kotob S, Pieruzzi F, et al. Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats. J Lab Clin Med 1997; 129:603-610. (Pubitemid 27288662)
79. Sharma AC, Singh G, Gulati A. Role of no mechanism in cardiovascular effects of diaspirin cross-linked hemoglobin In anesthetized rats. Am J Physiol-Heart Circul Physiol 1995; 38:H1379-H1388.
80. Thompson A, McGarry AE, Valeri CR, Lieberthal W. Stroma-free hemoglobin increases blood-pressure and gfr In the hypotensive rat: role of nitric-oxide. J Appl Physiol 1994; 77:2348-2354. (Pubitemid 24346444)
81. Sampei K, Ulatowski JA, Asano Y, et al. Role of nitric oxide scavenging In vascular response to cell-free hemoglobin transfusion. Am J Physiol-Heart Circul Physiol 2005; 289:H1191-H1201.
82. Reiter CD, Gladwin MT. An emerging role for nitric oxide in sickle cell disease vascular homeostasis and therapy. Curr Opin Hematol 2003; 10:99-107. (Pubitemid 36207963)
83. Reiter CD, Wang XD, Tanus-Santos JE, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med 2002; 8:13831389.
84. Ballas SK, Marcolina MJ. Hyperhemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Transfusion 2006; 46:105-110.
85. Naumann H, Diggs L, Barreras L, Williams B. Plasma hemoglobin and hemoglobin fractions in sickle cell crisis. Am J Clin Pathol 1971; 56:137-147.
86. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. J Am Med Assoc 2005; 293:1653-1662. (Pubitemid 40471796)
87. Takahashi Y, McCoy JP Jr, Carvallo C, et al. In vitro and In vivo evidence of PNH cell sensitivity to immune attack after nonmyeloablative allogeneic hematopoietic cell transplantation. Blood 2004; 103:1383-1390.
88. Boschetti C, Fermo E, Bianchi P, et al. Clinical and molecular aspects of 23 patients affected by paroxysmal nocturnal hemoglobinuria. Am J Hematol 2004; 77:36-44. (Pubitemid 39108795)
89. Jeffers A, Gladwin MT, Kim-Shapiro DB. Computation of plasma hemoglobin nitric oxide scavenging in hemolytic anemias. Free Radic Biol Med 2006; 41:1557-1565. (Pubitemid 44550083)
90. Pohl U, Lamontagne D. Impaired tissue perfusion after inhibition of endotheilum-derived nitric-oxide. Basic Res Cardiol 1991; 86:97-105.
91. Minneci PC, Deans KJ, Zhi H, et al. Hemolysis-associated endothelial dysfunction mediated by accelerated NO inactivation by decompartmentalized oxyhemoglobin. J Clin Invest 2005; 115:3409-3417.
92. Gladwin MT. Unraveling the hemolytic subphenotype of sickle cell disease. Blood 2005; 106:2925-2926. (Pubitemid 41565872)
93. Kato GJ, McGowan VR, Machado RF, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension and death in patients with sickle cell disease. Blood 2006; 107:2279-2285.
94. Nolan VG, Wyszynski DF, Farrer LA, Steinberg MH. Hemolysis-associated priapism in sickle cell disease. Blood 2005; 106:3264-3267. (Pubitemid 41565928)
95. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med 2004; 350:886-895.
96. Morris CR Kato GJ, Poijakovic M, et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. J Am Med Assoc 2005; 294:81-90.
97. Sakai H, Sato A, Masuda K, et al. Encapsulation of concentrated hemoglobin solution In phospholipid vesicles retards the reaction with NO, but not CO, by intracellular diffusion barrier. J Biol Chem 2008; 283:1508-1517.
98. Bernard A, Meier C, Lopez N, et al. Packed red blood cell-associated arginine depletion is mediated by arginase. J Trauma 2007; 63:1108-1112. (Pubitemid 350098535)
99. Prins HA, Houdijk APJ, Nijveldt RJ, et al. Arginase release from red blood cells: possible link In transfusion induced immune suppression? Shock 2001; 16:113-115.
100. Kleinbongard P, Schulz R, Rassaf T, et al. Red blood cells express a functional endothelial nitric oxide synthase. Blood 2006; 107:29432951.
101. Brooks J. The action of nitrite on haemoglobin in the absence of oxygen. Proc Roy Soc London B Biol Sci 1937; 123:368-382.
102. Doyle MP, Pickering RA, Deweert TM, et al. Kinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites. J Biol Chem 1981; 256:12393-12398.
103. Huang KT, Keszler A, Patel N, et al. The reaction between nitrite and deoxyhemoglobin: reassessment of reaction kinetics and stoichiometry. J Biol Chem 2005; 280:31126-31131.
104. Huang Z, Shiva S, Kim-Shapiro DB, et al. Enzymatic function of hemoglobin as a nitrite reductase that produces nitric oxide under allosterlc control. J Clin Invest 2005; 115:2099-2107.
105. Crawford JH, Isbell TS, Huang Z, et al. Hypoxia, red blood cells and nitrite regulate NO-dependent hypoxic vasodilatation. Blood 2006; 107:566574. (Pubitemid 43076380)
106. Basu S, Grubina R, Huang J, et al. Catalytic generation of N203 by a concerted nitrite reductase and anhydrase activity of hemoglobin. Nature Chem Biol 2007; 3:785-794.
107. Bennett-Guerrero E, Veldman TH, Doctor A, et al. Evolution of adverse changes in stored RBCs. Proc Natl Acad Sci USA 2007; 104:17063-17068. (Pubitemid 350210992)
108. Reynolds JD, Ahearn GS, Angelo M, et al. S-nitrosohemoglobin deficiency: a mechanism for loss of physiological activity In banked blood. Proc Natl Acad Sci USA 2007; 104:17058-17062. (Pubitemid 350210991)
109. Isbell TS, Sun CW, Wu LC, et al. SNO-hemoglobin is not essential for red blood cell-dependent hypoxic vasodilation. Nat Med 2008; 14:773-777
110. Kim-Shapiro DB, Gladwin MT. The functional nitrite reductase activity of the heme-globins. Blood 2008; 112:2636-2647
111. Szymanski IO, Teno RA, Lockwood WB, et al. Effect of rejuvenation and frozen storage on 42-day-old AS-1 RBCs. Transfusion 2001 ; 41:550-555.
112. Messana I, Ferroni L, Misiti F, et al. Blood bank conditions and RBCs: the progressive loss of metabolic modulation. Transfusion 2000; 40:353-360.
113. Knight JA, Searles DA, Clayton FC. The effect of desferrioxamine on stored erythrocytes: lipid peroxidation, deformability, and morphology. Ann Clin Laboratory Sci 1996; 26:283-290. (Pubitemid 26230823)
114. Barras JP, Moldovanyi A, Wagner S, Koerner K. Influence of rejuvenation on the rheological properties of stored red-cells. J Vasc Dis 1994; 23:305-311. (Pubitemid 24355306)
115. HeX, Azarov I, Jeffers A, et al. The potential of Angeli's salt to decrease nitric oxide scavenging by plasma hemoglobin. Free Radical Biol Med 2008; 44:1420-1432.
116. Minneci P, Deans K, Shiva S, et al. Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis. Am J Physiol Heart Circul Physiol 2008; 295:H743-H754.
117. Doyle MP, Mahapatro SN, Broene RD, Guy JK. Oxidation and reduction of hemoproteins by trioxodinitrate(li) : the role of nitrosyl hydride and nitrite. J Am Chem Soc 1988; 110:593-599.